Literature DB >> 11522401

c-DNA vaccination against parasitic infections: advantages and disadvantages.

W Kofta1, H Wedrychowicz.   

Abstract

Recently developed technology for DNA vaccination appears to offer the good prospect for the development of a multivalent vaccines that will effectively activate both the humoral and cell mediated mechanisms of the immune system. Currently, DNA vaccination against such important parasitic diseases like malaria, leishmaniosis, toxoplasmosis, cryptosporidiosis, schistosomosis, fasciolosis offers several new opportunities. However, the outcome of vaccination depends very much on vaccine formulations, dose and route of vaccine delivery, and the species and even strain of the vaccinated host. To overcome these problems much research is still needed, specifically focused on cloning and testing of new c-DNA sequences in the following: genome projects: different ways of delivery: design of vectors containing appropriate immunostimulatory sequences and very detailed studies on safety.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11522401     DOI: 10.1016/s0304-4017(01)00478-2

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  5 in total

1.  Characterization and vaccination of two novel Schistosoma japonicum genes screened from a cercaria cDNA library.

Authors:  Zhi Tian; Shi-Ping Wang; Shao-Hua Zeng; Xue-Qin Liu; Dong-Mei Gao; Qi-Mei Feng; Shu-Ju Zhang; Yun-Fei Zhou; Xi-Ya Wang; Ying-Ding Xia
Journal:  Parasitol Res       Date:  2011-07-08       Impact factor: 2.289

2.  Partial immunity to Fasciola hepatica in mice after vaccination with FhSAP2 delivered as recombinant protein or DNA construct.

Authors:  Ana M Espino; Adelaida Morales; Bonnibel Delgado; Francheska M Rivera; Olgary Figueroa; Erick Suárez
Journal:  Ethn Dis       Date:  2010       Impact factor: 1.847

3.  Comparing the effect of IL-12 genetic adjuvant and alum non-genetic adjuvant on the efficiency of the cocktail DNA vaccine containing plasmids encoding SAG-1 and ROP-2 of Toxoplasma gondii.

Authors:  Kamy Hosseinian Khosroshahi; Fatemeh Ghaffarifar; Zohre Sharifi; Sushila D'Souza; Abdolhosein Dalimi; Zuhair M Hassan; Fariba Khoshzaban
Journal:  Parasitol Res       Date:  2012-02-21       Impact factor: 2.289

4.  Development of a T cell-redirecting bispecific antibody targeting B-cell maturation antigen for the suppression of multiple myeloma cell growth.

Authors:  Jianxin Huo; Yuhan Huang; Ziying Zheng; Xin Ni Tay; Farouq Bin Mahfut; Wei Zhang; Kong-Peng Lam; Yuansheng Yang; Shengli Xu
Journal:  Antib Ther       Date:  2022-06-09

5.  Safety, immunogenicity, and cross-species protection of a plasmid DNA encoding Plasmodium falciparum SERA5 polypeptide, microbial epitopes and chemokine genes in mice and olive baboons.

Authors:  Nyamongo Onkoba; Ruth M Mumo; Horace Ochanda; Charles Omwandho; Hastings S Ozwara; Thomas G Egwang
Journal:  J Biomed Res       Date:  2017-07-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.